Answers are grounded in this paper and cite their sources.
Bispecific T-cell engagers (BiTEs) have revolutionized the care of multiple myeloma, markedly improving outcomes, promoting potent, off-the-shelf, anti-myeloma effects even in heavily pretreated pa...
No takes yet. Share an insight, caveat, or question.
Daunov et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: